Wake Forest University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Wake Forest University sits in the top decile of US sponsors by registered trial count (#240 of 15,742 sponsors by registered trial count).
Wake Forest University: 100 sponsored US clinical trials, 7 recruiting.
Wake Forest University sponsors 100 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 74 completed. 22 of these trials are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Urinary Incontinence, with 2 trials.
Top-decile sponsor footprint
Wake Forest University ranks in the top decile of sponsors by registered trial count (#240 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
74 of 92 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
100 total, page 1 of 2
Effects of Muscle Cooling on Motor Unit Firing of the Quadriceps
NCT07381920
A Mobile Intervention to Reduce Pain and Improve Health-III
NCT06623669
Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )
NCT06375694
The Osteoarthritis Prevention Study
NCT05946044
Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue
NCT05596474
The VESPA Pilot Study
NCT04756245
Muscle Fiber Fragment Treatment for Urinary Incontinence
NCT01953263
Revisiting A Mobile Intervention to Reduce Pain and Improve Health
NCT04655001
Stress Management in College Students
NCT05392621
The Cherokee Study: Cherokee Health for Elderly Residents With Osteoarthritis of the Knee
NCT04946344
Values Affirmation to Improve Teachers' Outcomes
NCT04241055
Nitrate and Exercise Performance in Middle to Older Aged Adults
NCT03371966
Efficacy Long-term Dietary Nitrate Consumption to Plasma Nitrite Conversion
NCT05380167
Weight Loss and Exercise for Communities With Arthritis in North Carolina
NCT02577549
Effect of High Protein Weight Loss for Seniors
NCT02730988
Muscle Progenitor Cell Therapy for Urinary Incontinence
NCT01953315
A Comparison of Scalp Blood Flow and Hair Shaft In Premenopausal Women Versus Postmenopausal Women
NCT01831180
Early Mobility for the Critically Injured Burn Patient
NCT01866735
Endogenous Pain Facilitation and Inhibition in Postpartum Women
NCT01843517
Lifestyle Intervention for Treatment of Diabetes
NCT01806727
Piedmont Aging, Cognition & Exercise Study-2
NCT02312843
Evaluation of FeNO During and Following Acute COPD Exacerbation
NCT01761006
Severe Asthma Research Program - Wake Forest University
NCT01750411
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
NCT01743976
Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris
NCT01707043
The Medication Experience Study
NCT01702883
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
NCT01674478
Using an Internet Study to Improve Adherence for Psoriasis Patients
NCT01802580
Lean Muscle Function
NCT01616498
Strength Training for ARthritis Trial
NCT01489462
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
NCT01469767
Effect of Samples on Acne Treatment With Epiduo® Gel
NCT01504204
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
NCT01561820
Rehabilitation and Exercise Training After Hospitalization
NCT01508650
Assessment of Muscle Function and Size in Older Adults With Rotator Cuff Tear
NCT01459536
Development and Validation of a Quality of Life Instrument for Actinic Keratosis
NCT01444989
Neuromuscular Ultrasound for Focal Neuropathies
NCT01394822
Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
NCT00779142
Touch and Attention MRI Study
NCT01432288
Pain and Function After Orthopedic Surgery
NCT01390298
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
NCT01590472
Supportive Intervention Programs Study
NCT01590147
Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones
NCT01343095
Azelaic Acid on Demodex Counts in Rosacea
NCT03035955
Measurement of Kidney Blood Flow and Oxygen Levels by MRI
NCT01318967
Study of Novel Approaches for Prevention
NCT01183689
Incidence of Respiratory Depression in Cesarean Section
NCT01181843
Improving Muscle for Functional Independence Trial
NCT01049698
Effect of Yoga on Objective and Subjective Menopausal Hot Flashes
NCT01073397
Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing
NCT00934661
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 10 |
| Phase 3 | 3 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Wake Forest University pipeline
7 recruiting of 100 indexed (7% open); 74 completed (74%).
Phase mix: 22 late (III/IV) vs 15 early (I/II) (balanced across stages).
Top condition: Urinary Incontinence (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University: open-pipeline peers nationwide
Peers matched on 100 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Wake Forest University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 100 trials (± recruiting share)
- UCB Pharma · 100 trials · 0% recruiting
- Spaulding Rehabilitation Hospital · 101 trials · 19% recruiting
- GE Healthcare · 99 trials · 8% recruiting
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 102 trials · 0% recruiting
Sponsors near 7% open enrollment (± trial volume)
- H. Lundbeck A/S · 7% recruiting · 72 trials
- Genentech · 7% recruiting · 332 trials
- State University of New York - Upstate Medical University · 7% recruiting · 113 trials
- BioCryst Pharmaceuticals · 7% recruiting · 29 trials
Related
What to do with this Wake Forest University page
100 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University or any single study.
- 7 of Wake Forest University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urinary Incontinence is the condition Wake Forest University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urinary Incontinence trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wake Forest University pipeline card: 100 registered trials from official public datasets.Report a data error.